Hørsholm, Denmark

Erik Daa Funder

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Hilleroed, DK (2023)
  • Hørsholm, DK (2022 - 2024)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Erik Daa Funder

Introduction

Erik Daa Funder, based in Hørsholm, Denmark, is an accomplished inventor with a significant contribution to the field of biotechnology. With a portfolio of 7 patents, he is recognized for his innovative approaches in oligonucleotide synthesis and therapeutic applications.

Latest Patents

Funder's latest inventions showcase his expertise in oligonucleotide technologies. One notable patent is for "Enhanced oligonucleotides for inhibiting RTEL1 expression," which presents antisense oligonucleotides aimed at targeting the Regulator of Telomere Elongation Helicase 1 (RTEL1). This patent also addresses their use in treating and preventing hepatitis B virus (HBV) infections, alongside pharmaceutical compositions derived from these oligonucleotides.

Another significant invention is his "Multiple coupling and oxidation method," which relates to the synthesis of stereodefined oligonucleotides. This method involves a process where the protected 5'-hydroxy terminus of a nucleoside is unprotected and then coupled with oxazaphospholidine phosphoramidite monomers, ultimately yielding higher purity and enhanced yields of the resultant oligonucleotides.

Career Highlights

Erik Daa Funder has worked with prominent organizations like Roche Innovation Center Copenhagen A/S and Hoffmann-La Roche Inc., where he honed his skills in the pharmaceutical and biotechnology sectors. His work has contributed significantly to advancements in genetic research and therapeutic developments.

Collaborations

During his career, Funder has collaborated with notable professionals in the industry, including Dennis Jul Hansen and Jacob Ravn. These partnerships have enabled the sharing of knowledge and expertise, fueling further innovation in their respective fields.

Conclusion

Erik Daa Funder stands out as a key figure in the biotechnology landscape with his patents that pave the way for new treatments and methodologies. His dedication to innovation continues to inspire advancements in medicinal chemistry and genetic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…